(Q26248603)

English

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

scientific article

In more languages

Statements

scholarly article

0 references

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial (English)

0 references

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events

0 references

0 references

atrial fibrillation

0 references

1 reference

based on heuristic

inferred from title

anticoagulation

1 reference

based on heuristic

inferred from title

author name string

S Connolly

2

0 references

J Pogue

3

0 references

R Hart

4

0 references

M Pfeffer

5

0 references

S Hohnloser

6

0 references

S Chrolavicius

7

0 references

S Yusuf

10

0 references

language of work or name

0 references

publication date

10 June 2006

0 references

0 references

367

0 references

1903-12

0 references

9526

0 references

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Why do patients with atrial fibrillation not receive warfarin?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin, aspirin, or both after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968845-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26248603&oldid=1398045648"